Clinical Trials FMF

• 
  Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
  FMF Clinical Trials, 2011-02-07 00:00:00

  
  From Clinicaltrials.gov :

  The primary purpose of this study is to assess the efficacy and safety of treatment with Kiacta in adult patients with AA Amyloidosis.
  

• 
  Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
  Clinical Trials - Muckle Wells, 0000-00-00 00:00:00

  
  Do not use the contact on the site but call the following number:
  

  Contact info:

  1-800-411-1222 begin_of_the_skype_highlighting            1-800-411-1222      end_of_the_skype_highlighting

  This study is currently recruiting participants.

  Purpose

  
  This study is designed to explore the genetics involved in diseases of intermittent fever, including familial Mediterranean fever, TRAPS, hyper-IgD syndrome, and related diseases.
  
  The following individuals may be eligible for this study: 1) patients 5 years of age and older with known or suspected familial Mediterranean fever, TRAPS, hyper-IgD syndrome or related disorders; 2) relatives of these patients; 3) healthy, normal volunteers 18 years of age or older; and 4) healthy patients with gout 18 years of age or older who are taking colchicine.

• 
  Heat Intolerance in the Group of FMF Patients
  Clinical Trials - Muckle Wells, 0000-00-00 00:00:00

  
  This study is enrolling participants by invitation only.

  Purpose

  There now causation between Heat Intolerance and FMF that were showed in studies till now. We suggest that the prevalence of Heat Intolerance in the group of the FMF patients will be significantly higher than in the group of healthy individuals, that participated in the study of Heller Institute of Medical Research. The aim of the study is verification of causation between these pathologies. The information obtained by the study may allow us to determine the sequence of events associated with FMF attack development, and perhaps take us one step further in the understanding of the pathogenesis of the disease.

  
  
  15 FMF patients with double mutations MEFV, mail sex, from the age from 18 to 30 without attacks during not less than 2 month will participate in the study. To identify an individuals susceptibility to exercise heat test, a Heat Tolerance Test (HTT) will perform, according to HTT Protocol of Heller Institute of Medical Research.